Catinazzo Thomas's Form 4 filing
Relay Therapeutics, Inc. (RLAY) · filed Apr 30, 2025
- Accession no.
- 0000950170-25-061366
- Filed
- Apr 30, 2025
- Trade date
- Apr 28-30, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market sales total $58.8K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Catinazzo ThomasCIK 0001818261 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 28, 2025 | Common Stock | SSaleDisposed | −1,709 | $3.17 | −$5,417.53 | 372,858 | Direct | |
| Apr 28, 2025 | Common Stock | SSaleDisposed | −981 | $3.17 | −$3,109.77 | 371,877 | Direct | |
| Apr 29, 2025 | Common Stock | SSaleDisposed | −3,558 | $3.23 | −$11,492.34 | 368,319 | Direct | |
| Apr 30, 2025 | Common Stock | SSaleDisposed | −12,943 | $3.00 | −$38,829 | 355,376 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.